IIPP’s applies a market co-creating and shaping framework to set out alternative policy approaches to redefine health innovation and create symbiotic innovation ecosystems, which is firmly rooted in the concept of public value and the common good. IIPP’s work in health, exemplified by the flagship report “The People's Prescription: Re-imagining Health Innovation to Deliver Public Value”, has generated policy impact both at high level policy discussions across the world.
Policy engagement highlights
- Engagements with the World Health Organization (WHO)
- On 8 June 2021, WHO Council on the Economics of Health For All called for health innovation to be governed by the common good.
- On 6 May 2021, Director Mariana Mazzucato chaired the first meeting of the WHO Council on the Economics of Health For All. Its initial 11 members are distinguished experts in economics, health, government, finance and development from around the world.
- On 13 November 2020, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus appoints IIPP Director Mariana Mazzucato to chair new Council on the Economics of Health for All.
- On 29 May 2020, IIPP Director Mariana Mazzucato speaks at the launch of the WHO COVID-19 Technology Access Pool (C-TAP) and endorses the Solidarity Call to Action to “realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data”.
- Engagements around the People's Prescription report
- On 6 September 2020, The United State National Institute of Health invited IIPP Director Mariana Mazzucato to give a seminar on the critical role of the public sector in innovation in health and beyond.
- On 14 May 2020, IIPP Director Mariana Mazzucato joined more than 140 world leaders and experts, including the President of South Africa and Chair of the African Union, Cyril Ramaphosa, the Prime Minister of Pakistan, Imran Khan, the President of the Republic of Senegal, Macky Sall and the President of the Republic of Ghana, Nana Addo Dankwa Akufo-Addo in calling for a People’s Vaccine against Covid-19.
- On 1st September 2019, IIPP’s health innovation report, ‘The people’s prescription: Re-imagining health innovation to deliver public value’, inspired the Labour Party’s 2019 pharmaceutical policy document, ‘Medicines for the Many: Public Health before Private Profit’.
- On 18 December 2018, IIPP Director Mariana Mazzucato supported the Affordable Drug Manufacturing Act introduced by US Senator Elizabeth Warren and Representative Jan Schakowsky to reduce drug prices through public manufacturing of prescription drugs.
To browse more IIPP policy briefs and policy reports, please visit our Policy Publications page.
Rethinking the economics of medical innovation
Funded by the Open Society Foundations
Learn more about health innovation research at IIPP.
Written by Mariana Mazzucato
- To control the pandemic, it is essential to suspend intellectual property rights on medical products related to covid-19 (The Economist)
- Capitalism won't save us from Covid, no matter waht Boris Johnson might think (The Guardian)
- Biden and the Promise of the People's Vaccine (Newsweek)
- Designing vaccines for people, not profits (Project Syndicate/Social Europe)
- Boris Johnson’s Failed COVID-19 Launch (Project Syndicate)
- Johnson has taken the wrong economic lesson from the Covid crisis (Financial Times)
- How to End the Pandemic This Year (Project Syndicate/WEF; featured as one idea among the top 5 ideas of the day in the newsletter of the Aspen Institute)
- How to Develop a COVID-19 Vaccine for All (Project Syndicate/WEF)
- Drug Companies Will Make a Killing From Coronavirus (The New York Times)
- Capitalism’s Triple Crisis (Project Syndicate)
- The Covid-19 Crisis Is a Chance to Do Capitalism Differently (The Guardian)
- Putting the Public Back in Public Health (Project Syndicate)
- Big Pharma is hurting drug innovation (The Washington Post)
- The NHS is being impeded by greedy drug companies (The Times)
Written by IIPP academic staff and collaborators
- Preparing for the next pandemic requires public health focused industrial policy (BMJ) by Els Toreele
- As politics trumps science in the race for a vaccine, who will protect public health? (BMJ) by Els Torreele
- Collective intelligence, not market competition, will deliver the best Covid-19 vaccine (STAT) by Els Torreele
- The rush to create a covid-19 vaccine may do more harm than good (BMJ) by Els Torreele
- Biopharma Companies Are Taking Advantage of Their Misinformation (STAT) by Travis Whitfill
- The Coronavirus Drug Remdesivir Is a Big Deal. But How Much Will It Cost? (Newsweek) by Victor Roy
- Who Benefits When the Price of Insulin Soars? (Institute for New Economic Thinking) by Rosie Collington
- Media highlights
- World Health Organization media briefing on Covid-19 (and on the Council on the Economics of Health for All staring from 9:00)
- How much is Your Health Worth? The Human and Economic Value of Health in the Era of Covid-19
- Health needs to be at the centre of comprehensive economic policy (The Washington Post)
- Reimagining the economy after Coronavirus (CNN)
- People’s vaccine (BBC World News)
- The Race for a Vaccine (CoronaNomics)
IIPP news stories
- News stories
- WHO Council on Economics for Health for All calling for health innovation to be governed by common good
- Global experts of new WHO Council on the Economics of Health For All announced
- IIPP Director Mariana Mazzucato to chair new WHO Council on the Economics of Health for All
- Pope Francis cites work of IIPP Director Mariana Mazzucato in latest book
- Leading medical innovation and access policy expert joins IIPP
- Data driven innovation expert Carol Sinclair joins IIPP
- IIPP applies an analytical lens to the COVID-19 crisis in a new series of public briefs
- IIPP launches a new global engagement series: Public purpose in the time of COVID-19
- IIPP selected to take part in Vatican COVID-19 Commission’s Economy Taskforce
- Living healthier or living longer? IIPP responds to the grand challenge of an ageing society
- Health innovation: creative approaches to improving access to medicines globally
- Labour Party draw on IIPP health innovation research for new pharma policy
- IIPP and the British Library partner on new 2019 lecture series, "Innovation and the Welfare State”
- The People's Prescription report calls for a transformation of the health innovation system
For more information on our work in health innovation policy, please contact Henry Lishi Li, Research Fellow in Health Innovation at IIPP: